Last update 04 Nov 2024

Hangzhou Ruizhen Pharmaceutical Co., Ltd

Private Company|
2019|
Zhejiang Sheng, China

Overview

Tags

Digestive System Disorders
Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
Top II(Topoisomerase II)1

Related

1
Drugs associated with Hangzhou Ruizhen Pharmaceutical Co., Ltd
Tirapazamine
Target
Top II
Mechanism
Top II inhibitors
Active Org.
Teclison Ltd.Teclison Ltd.Startup [+3]
Originator Org.
SRI InternationalSRI International
Active Indication
Head and Neck Neoplasms [+8]
Inactive Indication
Advanced Head and Neck Carcinoma [+6]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Hangzhou Ruizhen Pharmaceutical Co., Ltd
CTR20230034 / RecruitingPhase 2
经肝动脉注射替拉扎明再行肝动脉栓塞（TATE）与KN046联合治疗晚期肝转移性结直肠癌（MSS/ pMMR）的IIA期临床试验
[Translation] A phase IIA clinical trial of transarterial tirapazamine followed by hepatic arterial embolization (TATE) combined with KN046 in the treatment of advanced liver metastatic colorectal cancer (MSS/pMMR)
CTR20243479 / Not yet recruitingPhase 2/3
研究经肝动脉注射替拉扎明后再行肝动脉栓塞（TATE）治疗中期原发性肝细胞癌是否优于传统经肝动脉化疗栓塞（TACE）的多中心、随机、对照、开放的 II/III 期临床试验
[Translation] A multicenter, randomized, controlled, open-label phase II/III clinical trial to investigate whether transarterial embolization (TATE) followed by tirapazamine is superior to conventional transarterial chemoembolization (TACE) in the treatment of intermediate-stage primary hepatocellular carcinoma
100 Clinical Results associated with Hangzhou Ruizhen Pharmaceutical Co., Ltd
Login to view more data
0 Patents (Medical) associated with Hangzhou Ruizhen Pharmaceutical Co., Ltd
Login to view more data
100 Deals associated with Hangzhou Ruizhen Pharmaceutical Co., Ltd
Login to view more data
100 Translational Medicine associated with Hangzhou Ruizhen Pharmaceutical Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Tirapazamine
 ( Top II )		Hepatocellular Carcinoma
More
Phase 2/3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free